Union Health Minister Mansukh Mandaviya, who chaired a meeting of the country's key experts on the new XE variant' of coronavirus, directed officials to boost the ongoing monitoring and surveillance of new variants and cases.
He also asked the officials to constantly review the availability of essential drugs and medicines required in the treatment of COVID-19 patients, a statement from the ministry read.
The minister further emphasized on carrying out the ongoing vaccination drive at full pace and to vaccinate all eligible candidates, the statement said.
The meeting was attended by Dr VK Paul, Member (Health), NITI Ayog; Rajesh Bhushan, Secretary, Health; Dr Randip Guleria, Director, AIIMS; Dr Balrama Bhargava, Director General, ICMR; Dr. N K Arora, chief of National Technical Advisory Group on Immunisation in India, and other senior officials of the health ministry.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)